133 related articles for article (PubMed ID: 6428688)
21. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease.
de Ritis G; Auricchio S; Jones HW; Lew EJ; Bernardin JE; Kasarda DD
Gastroenterology; 1988 Jan; 94(1):41-9. PubMed ID: 3335296
[TBL] [Abstract][Full Text] [Related]
22. An in vitro model for gluten enteropathy.
Nutr Rev; 1980 Apr; 38(4):161-3. PubMed ID: 7207883
[No Abstract] [Full Text] [Related]
23. In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.
Beguinot L; Auricchio S; Bernardin JE; de Ritis G; De Vincenzi M; Kasarda DD; Macchia V; Silano V
Pediatr Res; 1986 Jan; 20(1):42-4. PubMed ID: 3945514
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus.
De Ritis G; Occorsio P; Auricchio S; Gramenzi F; Morisi G; Silano V
Pediatr Res; 1979 Nov; 13(11):1255-61. PubMed ID: 390482
[TBL] [Abstract][Full Text] [Related]
25. [In vitro intestinal cytotoxicity of various fractions from gliadin or cows's milk proteins in children: quantitative assessment by a morphometric method].
Olives JP; Schmitz J; Jos J; de Tand MF; Rey J
Gastroenterol Clin Biol; 1982; 6(6-7):557-62. PubMed ID: 7117767
[No Abstract] [Full Text] [Related]
26. Stimulation of lymphocytes from patients with coeliac disease by subfraction of gluten.
Lancet; 1976 Sep; 2(7986):629-30. PubMed ID: 61364
[No Abstract] [Full Text] [Related]
27. A catalogue of Triticum monococcum genes encoding toxic and immunogenic peptides for celiac disease patients.
Vaccino P; Becker HA; Brandolini A; Salamini F; Kilian B
Mol Genet Genomics; 2009 Mar; 281(3):289-300. PubMed ID: 19104838
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic effects of wheat gliadin-derived peptides.
Paganuzzi AS; Zucco F; Cardelli M; de Angelis I; Mattei R; Pino A; Rocca E; Zampaglioni F
Toxicology; 1985 Dec; 37(3-4):225-32. PubMed ID: 4071551
[TBL] [Abstract][Full Text] [Related]
29. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
[TBL] [Abstract][Full Text] [Related]
30. Wheat starch, gliadin, and the gluten-free diet.
Thompson T
J Am Diet Assoc; 2001 Dec; 101(12):1456-9. PubMed ID: 11762742
[TBL] [Abstract][Full Text] [Related]
31. Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease.
Howdle PD
Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):703-6. PubMed ID: 16772825
[TBL] [Abstract][Full Text] [Related]
32. Abnormal behavior after intracerebral injection of polypeptides from wheat gliadin: possible relevance to schizophrenia.
Dohan FC; Levitt DR; Kushnir LD
Pavlov J Biol Sci; 1978; 13(2):73-82. PubMed ID: 567316
[No Abstract] [Full Text] [Related]
33. Prevention by a decapeptide from durum wheat of in vitro gliadin peptide-induced apoptosis in small-bowel mucosa from coeliac patients.
Silano M; Leonardi F; Trecca A; Mancini E; Di Benedetto R; De Vincenzi M
Scand J Gastroenterol; 2007 Jun; 42(6):786-7. PubMed ID: 17506006
[No Abstract] [Full Text] [Related]
34. Letter: Sequence comparison of gamma-gliadin and coeliac-toxic alpha-gliadin.
Patey AL; Evans DJ; Tiplady R; Byfield PG; Matthews EW
Lancet; 1975 Oct; 2(7937):718. PubMed ID: 52101
[No Abstract] [Full Text] [Related]
35. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
[TBL] [Abstract][Full Text] [Related]
36. Agglutinating activity of wheat gliadin peptide fractions in coeliac disease.
De Vincenzi M; Dessi MR; Giovannini C; Maialetti F; Mancini E
Toxicology; 1995 Jan; 96(1):29-35. PubMed ID: 7863509
[TBL] [Abstract][Full Text] [Related]
37. The binding of a glycopeptide component of wheat gluten to intestinal mucosa of normal and coeliac human subjects.
Douglas AP
Clin Chim Acta; 1976 Dec; 73(2):357-61. PubMed ID: 1000854
[TBL] [Abstract][Full Text] [Related]
38. [Coeliac disease--new clinical findings and diagnostic tools].
Lundin KE; Farstad IN; Sollid LM
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3226-9. PubMed ID: 14714016
[TBL] [Abstract][Full Text] [Related]
39. The toxicity of certain cereal proteins in coeliac disease.
Cornell HJ; Townley RR
Gut; 1974 Nov; 15(11):862-9. PubMed ID: 4455563
[TBL] [Abstract][Full Text] [Related]
40. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
